Leukemia inhibitory factor: an important regulator of endometrial function

Zdzisława Kondera-Anasz1, Justyna Sikora, Aleksandra Mielczarek-Palacz

  • 1Department of Immunology and Serology, Silesian Medical Academy in Katowice, Poland.

Insights

Leukemia inhibitory factor (LIF) is crucial for endometrial function and implantation. Impaired LIF expression is linked to infertility, highlighting its role in human reproduction.

Area of Science:

  • Reproductive biology
  • Cellular and molecular biology

Background:

  • Leukemia inhibitory factor (LIF) is a multifunctional cytokine with diverse biological activities.
  • LIF influences various cell types, including those within the endometrium.

Purpose of the Study:

  • To elucidate the implications of LIF on the physiological functions of the human endometrium.
  • To review and summarize the existing literature on LIF's role in endometrial physiology.

Main Methods:

  • A comprehensive literature review was conducted.
  • Data on LIF expression and function in the endometrium were synthesized.

Main Results:

  • LIF expression in the endometrium is dynamic, influenced by cellular localization, hormones, menstrual cycle phase, and cytokine networks.
  • Elevated LIF expression is observed in the endometrial epithelium during the luteal phase, coinciding with the window of implantation.
  • Deficiencies in endometrial LIF expression are implicated in implantation failures and infertility.

Conclusions:

  • Leukemia inhibitory factor (LIF) is a key regulator of endometrial function.
  • LIF plays a significant role in successful human reproduction.
  • Dysregulation of LIF may contribute to reproductive pathologies.
Abstract

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...